These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1225 related items for PubMed ID: 18598692

  • 21. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
    Tanaka K, Tanaka Y, Namba T, Azuma A, Mizushima T.
    Biochem Pharmacol; 2010 Sep 15; 80(6):920-31. PubMed ID: 20513440
    [Abstract] [Full Text] [Related]

  • 22. [Losartan in the rat model of bleomycin-induced pulmonary fibrosis and its impact on the expression of monocyte chemoattractant protein-1 and basic fibroblast growth factor].
    Fang X, Zhu Y, Hu X, Liu Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 May 15; 25(5):268-72. PubMed ID: 12133317
    [Abstract] [Full Text] [Related]

  • 23. Overexpression of MMP9 in macrophages attenuates pulmonary fibrosis induced by bleomycin.
    Cabrera S, Gaxiola M, Arreola JL, Ramírez R, Jara P, D'Armiento J, Richards T, Selman M, Pardo A.
    Int J Biochem Cell Biol; 2007 May 15; 39(12):2324-38. PubMed ID: 17702637
    [Abstract] [Full Text] [Related]

  • 24. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis.
    Baecher-Allan CM, Barth RK.
    Reg Immunol; 1993 May 15; 5(3-4):207-17. PubMed ID: 7694632
    [Abstract] [Full Text] [Related]

  • 25. Pirfenidone inhibits carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents by preventing activation of hepatic stellate cells.
    Zhao XY, Zeng X, Li XM, Wang TL, Wang BE.
    Clin Exp Pharmacol Physiol; 2009 Oct 15; 36(10):963-8. PubMed ID: 19413596
    [Abstract] [Full Text] [Related]

  • 26. Feitai, a Chinese herbal medicine, reduces transforming growth factor-beta1 and monocyte chemoattractant protein-1 expression in bleomycin-induced lung fibrosis in mice.
    Shen Y, Zhao HL, Du J, Li YT, Tan F, Huang CG, Pei G.
    Clin Exp Pharmacol Physiol; 2005 Dec 15; 32(12):1071-7. PubMed ID: 16445573
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis.
    Brewer GJ, Dick R, Ullenbruch MR, Jin H, Phan SH.
    J Inorg Biochem; 2004 Dec 15; 98(12):2160-7. PubMed ID: 15541506
    [Abstract] [Full Text] [Related]

  • 28. Lung cytokine production in bleomycin-induced pulmonary fibrosis.
    Phan SH, Kunkel SL.
    Exp Lung Res; 1992 Dec 15; 18(1):29-43. PubMed ID: 1374023
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A further investigation concerning correlation between anti-fibrotic effect of liposomal quercetin and inflammatory cytokines in pulmonary fibrosis.
    Baowen Q, Yulin Z, Xin W, Wenjing X, Hao Z, Zhizhi C, Xingmei D, Xia Z, Yuquan W, Lijuan C.
    Eur J Pharmacol; 2010 Sep 10; 642(1-3):134-9. PubMed ID: 20510684
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Naringenin: a potential immunomodulator for inhibiting lung fibrosis and metastasis.
    Du G, Jin L, Han X, Song Z, Zhang H, Liang W.
    Cancer Res; 2009 Apr 01; 69(7):3205-12. PubMed ID: 19318568
    [Abstract] [Full Text] [Related]

  • 33. Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.
    Russo RC, Alessandri AL, Garcia CC, Cordeiro BF, Pinho V, Cassali GD, Proudfoot AE, Teixeira MM.
    Am J Respir Cell Mol Biol; 2011 Jul 01; 45(1):72-80. PubMed ID: 20833968
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Suplatast tosilate prevents bleomycin-induced pulmonary fibrosis in mice.
    Furonaka M, Hattori N, Tanimoto T, Senoo T, Ishikawa N, Fujitaka K, Haruta Y, Yokoyama A, Kohno N.
    J Pharmacol Exp Ther; 2009 Jan 01; 328(1):55-61. PubMed ID: 18832650
    [Abstract] [Full Text] [Related]

  • 37. Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats.
    Zhou XM, Zhang GC, Li JX, Hou J.
    J Ethnopharmacol; 2007 May 04; 111(2):255-64. PubMed ID: 17188826
    [Abstract] [Full Text] [Related]

  • 38. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.
    Iyer SN, Gurujeyalakshmi G, Giri SN.
    J Pharmacol Exp Ther; 1999 Apr 04; 289(1):211-8. PubMed ID: 10087006
    [Abstract] [Full Text] [Related]

  • 39. EM703 improves bleomycin-induced pulmonary fibrosis in mice by the inhibition of TGF-beta signaling in lung fibroblasts.
    Li YJ, Azuma A, Usuki J, Abe S, Matsuda K, Sunazuka T, Shimizu T, Hirata Y, Inagaki H, Kawada T, Takahashi S, Kudoh S, Omura S.
    Respir Res; 2006 Jan 27; 7(1):16. PubMed ID: 16438734
    [Abstract] [Full Text] [Related]

  • 40. (5R)-5-hydroxytriptolide (LLDT-8) protects against bleomycin-induced lung fibrosis in mice.
    Ren YX, Zhou R, Tang W, Wang WH, Li YC, Yang YF, Zuo JP.
    Acta Pharmacol Sin; 2007 Apr 27; 28(4):518-25. PubMed ID: 17376291
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 62.